Streetbeat News

Products Services

SILO

Silo Pharma shares are trading higher after the company entered into an agreement with WuXi AppTec for a preclinical small animal study of SPU-16.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:15 pm

SILO

Silo Pharma has partnered with a global Contract Research Organization (CRO) to study the SPU-16 peptide's ability to target inflamed epithelium in an experimental autoimmune encephalomyelitis (EAE) model, commonly used for multiple sclerosis (MS). This partnership aims to explore the peptide's potential as a targeted drug delivery tool for spinal cord inflammation. Shares of Silo Pharma moved higher following the announcement.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:14 pm

ALNY

Alnylam Pharmaceuticals will present the HELIOS-B Phase 3 study results of Vutrisiran at the ESC Congress 2024. The topline results show a significant reduction in mortality and cardiovascular events. The company will host a conference call and investor webcast on August 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:14 pm

ABT

MDT

Abbott has announced a global partnership with Medtronic to integrate its FreeStyle Libre CGM sensors with Medtronic's insulin delivery systems. This partnership expands connectivity with four major automated insulin delivery companies.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:13 pm

DOGEUSD

Dogecoin (DOGE) has rebounded to $0.10, showing a 15% increase from its recent bottom. Analysts are optimistic about further gains if DOGE breaks the $0.10 mark, with a key resistance level at $0.143. Despite market downturns, DOGE has shown resilience by closing above the 200-day SMA. However, challenges remain, and a confirmed bullish trend is yet to be seen.

Portfolio Pulse from Khyathi Dalal

August 07, 2024 | 12:12 pm

CM

CIBC has announced a strategic collaboration with Creative Destruction Lab to empower companies through AI innovation. This partnership aims to leverage AI to drive growth and innovation for businesses.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:10 pm

SNOW

TRU

TransUnion has partnered with Snowflake to launch TruIQ Data Enrichment on the Snowflake Marketplace. This collaboration provides joint customers with on-demand access to pseudonymized TransUnion credit data.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:09 pm

MDT

Medtronic has received FDA approval for its new Simplera product, which is expected to enhance its market position in the medical device industry.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:06 pm

NAII

Natural Alternatives International (NAII) has launched TriBsyn, a new carnosine booster that uses CarnoSyn® Beta-Alanine and patent-pending technology to improve bioavailability and absorption, while eliminating paresthesia.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:03 pm

EYEN

Formosa Pharmaceuticals has signed a non-binding terms agreement with Eyenovia to co-develop Clobetasol Propionate Ophthalmic Suspension for the relief of dry eye disease.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 12:01 pm